Anatomical and refractive outcomes in patients with treated retinopathy of prematurity.

CONCLUSION: Treatment with laser or intravitreal bevacizumab is a highly successful primary treatment for ROP. Anatomical success can be achieved in most cases. Treated patients develop frequent and severe refractive defects, which should be corrected. Vision outcome, measured using the Teller preferential test, shows good results.
PMID: 28624314 [PubMed - as supplied by publisher]

Source: Archivos de la Sociedad Espanola de Oftalmologia - June 20, 2017 Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research